
Velcheti Evaluates Activity of Repotrectinib for ROS1 Fusion–Positive NSCLC
Vamsidhar Velcheti, MD Professor, Department of Medicine NYU Grossman School of Medicine Director, Thoracic Med Oncology Program NYU Langone Medicine New York, NY CASE SUMMARY A 59- year-old woman presents to her primary care physician with chief concerns …